To visit the old Ventura website, click here.
Ventura Wealth Clients Login here

NSEBSE
NSEBSE
noteThere is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
1D
1W
1M
1Y
3Y
5Y
Max
Open-
High-
Low-
Prev. Close-
Avg. Traded Price-
Volume-

MARKET DEPTH

info2
Total bid0.00
Total ask0.00
OrdersQtyBid
AskQtyOrders

HIGH/LOW

info2
1d
1w
1m
3m
52w

LOW/HIGH

172.65a day ago
178.80a day ago
arrow

LOWER/UPPER CIRCUITS

141.06
211.59
arrow
Bliss Gvs Pharma Ltd Stock performance
arrow

KEY OBSERVATIONS

info
positive
negative
neutral
noteAnnual Revenue,rose 5.91%, in the last year to ₹846.22 Cr. Its sector's average revenue growth for the last fiscal year was 10.77%.
noteAnnual Net Profit,rose 11.72% in the last year to ₹84.3 Cr. Its sector's average net profit growth for the last fiscal year was 38.71%.
notePrice to Earning Ratio,is 17.2, lower than its sector PE ratio of 43.86.
View more

LONG-TERM PRICE ANALYSIS

info
Stock return5Y CAGR : -8.86%
Net profit growth 5Y CAGR : -8.42%
Bliss Gvs Pharma Ltd Top mutual funds holding
arrow
Bliss GVS Pharma Limited is a fast-growing Pharmaceutical Company with a proven track record of developing manufacturing and marketing high quality pharmaceutical formulations at affordable prices for the global market. It is among the world leaders in Suppositories and Pessaries dosage forms with one of the largest portfolios in this segment. Over the last decade it has acquired definitive know-how in other dosage forms & therapeutic segments which is exemplified by its ever-expanding product offering across more than sixty countries. With significant expansion in R & D Manufacturing & Marketing capabilities it is poised for an accelerated rate of growth which makes for very exciting times at Bliss GVS.
personal

Grow your wealth with more research recommendations

+91